Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
OPHLY ONO PHARMACEUTICAL CO UNSP ADR REPR 0.3333 ORD
8.510
-0.020-0.23%
YOY
Do not show
Hide blank lines
(Q1)2022/06/30(FY)2022/03/31(Q4)2022/03/31(Q3)2021/12/31
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
-8.25% 111.7248 -15.47% 77.5685 -15.47% 77.5685 -6.25% 108.4047
Receivable Turnover(T)
-0.82% 3.7643 2.27% 3.9266 2.27% 3.9266 2.41% 3.631
Inventory Turnover(T)
0.27% 2.379 -2.75% 2.3098 -2.75% 2.3098 -2.15% 2.3194
Fixed Assets Turnover(T)
19.52% 3.4007 18.13% 3.1979 18.13% 3.1979 15.62% 3.0525
Total Asset Rate(T)
11.61% 0.5052 11.67% 0.4863 11.67% 0.4863 8.13% 0.474
ROIC
3.54% 12.689% -0.10% 12.084% -0.10% 12.084% -8.31% 11.048%
ROE
2.74% 13.054% -0.97% 12.470% -0.97% 12.470% -8.27% 11.464%
ROA
3.89% 11.403% 2.03% 10.837% 2.03% 10.837% -6.56% 10.083%
FCF to Sales
39.76% 20.591% -21.00% 13.713% -21.00% 13.713% -37.09% 11.057%
FCF to Net Income
50.14% 91.240% -13.54% 61.541% -13.54% 61.541% -27.19% 51.977%
Efficiency Ratios
ROE 5 Year Average
-- -- 2.24% 10.978% -- -- -- --
ROA 5 Year Average
-- -- 2.63% 9.360% -- -- -- --
Average 5 Years ROIC
-- -- 2.46% 10.523% -- -- -- --
Profitability Ratios TTM
Gross Margin
2.26% 74.352% 2.48% 74.123% 2.48% 74.123% 2.29% 73.956%
Operating Margin
-6.73% 29.304% -10.18% 28.558% -10.18% 28.558% -8.28% 28.431%
Net Margin
-6.91% 22.568% -8.63% 22.282% -8.63% 22.282% -13.59% 21.273%
EBITDA Margin
-7.22% 0.3463% -9.45% 0.3421% -9.45% 0.3421% -7.85% 0.3413%
R & D Expense Ratio
3.65% 21.030% 4.12% 21.000% 4.12% 21.000% -8.55% 19.670%
Sales Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Administration Expense Rate
-8.83% 20.970% -4.74% 21.320% -4.74% 21.320% 5.53% 22.700%
Financial Health Ratios
Long-Term Debt to Equity Ratio
-11.60% 0.949% -10.40% 0.991% -10.40% 0.991% -9.87% 1.024%
Total Assets to Common Equity
-1.33% 113.736% -4.10% 112.700% -4.10% 112.700% -3.00% 112.017%
Debt to Asset Ratio
-6.26% 1.287% -5.78% 1.342% -5.78% 1.342% -5.26% 1.377%
Current Ratio
38.05% 4.1595 61.48% 4.2664 61.48% 4.2664 39.03% 4.3409
Quick Ratio
44.10% 3.2838 62.85% 3.2879 62.85% 3.2879 42.74% 3.4323
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- 36.26% 7.778% -- -- -- --
Revenue CAGR(5Y)
-- -- -42.34% 8.100% -- -- -- --
Net Income CAGR(3Y)
-- -- 10.81% 16.035% -- -- -- --
Net Income CAGR(5Y)
-- -- -69.22% 7.613% -- -- -- --
Dividend CAGR(3Y)
-- -- 19.41% 5.025% -- -- -- --
Dividend CAGR(5Y)
-- -- 14.13% 7.086% -- -- -- --
FCF 1 Year Growth
-- -- -301.84% -7.697% -- -- -- --
FCF CAGR(3Y)
-- -- -- 10.056% -- -- -- --
FCF CAGR(5Y)
-- -- -- -0.327% -- -- -- --
Currency Unit
JPYJPYJPYJPY

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Ono Pharmaceutical Co., Ltd. engages in the production, purchase, and sale of internal medicine, patch and injectable medicine. The company was founded by Ichibei Fushimiya in 1717 and is headquartered in Osaka, Japan.
CEO: Mr. Gyo Sagara
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist